Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Khiron Life Sciences Corp.
  6. News
  7. Summary
    KHRN   CA49374L3065

KHIRON LIFE SCIENCES CORP.

(KHRN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Khiron Life Sciences : Medical Cannabis Company Khiron Life Sciences Outlines Results of First Research Study

10/07/2021 | 10:36am EST


ę MT Newswires 2021
All news about KHIRON LIFE SCIENCES CORP.
11/23Khiron Announces Grants of Options and Restricted Share Units
AQ
11/22Khiron Life Sciences' Q3 Loss Narrows YoY as Revenues Rise
MT
11/22Khiron Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
11/22Khiron Life Sciences Corp. acquired Mcs Clinics Limited for 0.3 million.
CI
11/09KHIRON LIFE SCIENCES CORP. : Invitation to the Q4 Virtual Investor Summit
NE
11/08Khiron Life Sciences to Present at Upcoming November Investor Conferences
PR
11/03Khiron Opens First clinic in Europe with Zerenia™ Clinics UK
AQ
11/03Khiron Life Sciences Corp. Opens First clinic in Europe with Zerenia? Clinics UK
CI
10/07KHIRON LIFE SCIENCES : Medical Cannabis Company Khiron Life Sciences Outlines Results of F..
MT
10/07KHIRON LIFE SCIENCES CORP. : Invitation to the Benzinga Cannabis Capital Conference
NE
More news
Financials
Sales 2021 13,1 M 10,4 M 10,4 M
Net income 2021 -22,2 M -17,5 M -17,5 M
Net Debt 2021 15,0 M 11,9 M 11,9 M
P/E ratio 2021 -1,10x
Yield 2021 -
Capitalization 39,4 M 31,2 M 31,1 M
EV / Sales 2021 4,15x
EV / Sales 2022 1,90x
Nbr of Employees -
Free-Float 95,2%
Chart KHIRON LIFE SCIENCES CORP.
Duration : Period :
Khiron Life Sciences Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KHIRON LIFE SCIENCES CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,22 CAD
Average target price 0,85 CAD
Spread / Average Target 286%
EPS Revisions
Managers and Directors
┴lvaro F. Torres Chief Executive Officer & Director
Swapan Kakumanu Chief Financial Officer
Chris Naprawa Chairman
Jairo Espinoza Vice President-Medical Affairs
Manuel Buendia Vice President-Operations